Breaking News Instant updates and real-time market news.

GS

Goldman Sachs

$255.53

2.37 (0.94%)

, BLK

BlackRock

$521.27

-4.11 (-0.78%)

04:55
02/14/18
02/14
04:55
02/14/18
04:55

Credit Suisse to hold a forum

19th Annual Financial Services Forum to be held in Miami on February 12-14.

GS

Goldman Sachs

$255.53

2.37 (0.94%)

BLK

BlackRock

$521.27

-4.11 (-0.78%)

TWO

Two Harbors

$15.09

0.09 (0.60%)

CME

CME Group

$160.16

0.03 (0.02%)

CG

Carlyle Group

$23.45

-0.1 (-0.42%)

DFS

Discover

$76.50

0.55 (0.72%)

KKR

KKR

$21.25

-0.28 (-1.30%)

RF

Regions Financial

$18.85

0.38 (2.06%)

C

Citi

$75.18

0.42 (0.56%)

SLM

Sallie Mae

$10.91

-0.04 (-0.37%)

BX

Blackstone

$33.55

0.27 (0.81%)

OAK

Oaktree Capital

$42.65

-0.1 (-0.23%)

MS

Morgan Stanley

$53.39

-0.04 (-0.07%)

SPGI

S&P Global

$181.94

1.58 (0.88%)

MTGE

MTGE Investment

$17.25

0.25 (1.47%)

NTRS

Northern Trust

$99.35

-0.01 (-0.01%)

  • 14

    Feb

  • 22

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 07

    Mar

  • 13

    Mar

  • 30

    May

GS Goldman Sachs
$255.53

2.37 (0.94%)

01/25/18
WELS
01/25/18
NO CHANGE
Target $320
WELS
Outperform
Goldman Sachs price target raised to $320 from $295 at Wells Fargo
Wells Fargo analyst Mike Mayo raised his price target for Goldman Sachs to $320 form $295 saying it should have the highest pre-tax margin this decade by 2019. The analyst notes that Goldman has preserved more of its infrastructure than peer even while reducing comp and non-comp expense, which should result in greater revenues at lower marginal cost. Mayo reiterates an Outperform rating on the shares.
01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
01/18/18
RBCM
01/18/18
NO CHANGE
Target $265
RBCM
Sector Perform
Goldman Sachs price target raised to $265 from $240 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Goldman Sachs to $265 and kept his Sector Perform rating following Q4 earnings. Cassidy contends that the weak trading results, particularly in FICC, were more than offset by Goldman's "diversified revenue mix, led by strong Investment banking results and private equity gains". The analyst also notes the company's efforts to grow and deepen relationships across its major businesses, while deriving further benefits from the "actual and perceived loosening of regulations under the Trump administration".
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
BLK BlackRock
$521.27

-4.11 (-0.78%)

01/16/18
ARGS
01/16/18
NO CHANGE
Target $170
ARGS
Buy
PNC Financial price target raised to $170 from $150 at Argus
Argus analyst Stephen Biggar raised his price target on PNC Financial (PNC) to $170, citing the company's Q4 earnings beat that also featured a 9% rise in net interest income, a 5% increase in average loans, and a 19bps net interest margin expansion. The analyst also notes PNC Financial's management forecasting a 2018 effective tax rate of 17%, down from 25% paid in 2017. Biggar keeps his Buy rating on PNC Financial, adding that the stock should trade at a premium to peers based on its 21% stake in BlackRock (BLK) which offers a "healthy" recurring dividend stream.
01/16/18
ARGS
01/16/18
NO CHANGE
Target $620
ARGS
Buy
BlackRock price target raised to $620 from $520 at Argus
Argus analyst Stephen Biggar raised his price target on BlackRock to $620, citing the company's Q4 earnings beat and higher than expected Q4 inflows. The analyst also notes BlackRock's anticipated effective tax rate in 2018 reduced to 23% from 29% in 2017 and higher asset levels to begin the new year. Biggar keeps his Buy rating on BlackRock, adding that the stock should trade at a premium valuation relative to peers based on its "above-average operating margins, stable long-term asset inflows, and a history of product innovation".
01/25/18
SBSH
01/25/18
DOWNGRADE
Target $625
SBSH
Neutral
BlackRock downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded BlackRock to Neutral saying the "revaluation thesis" is now well understood . The analyst sees less positive earnings and valuation surprise potential at current stock levels. He keeps a $625 price target for BlackRock shares.
01/25/18
01/25/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Discover (DFS) downgraded to In Line from Outperform at Evercore ISI. 2. BlackRock (BLK) downgraded to Neutral from Buy at Citi with analyst William Katz saying the "revaluation thesis" is now well understood. 3. bluebird bio (BLUE) downgraded to Market Perform from Outperform at Leerink with analyst Michael Schmidt saying the company's clinical stage pipeline now is fairly valued while visibility into additional near-term sources of upside is limited. 4. Jagged Peak Energy (JAG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Scott Hanold citing a tight frac service market in the Permian that lowers his projected growth outlook, saying the company is "more susceptible to frac service constraints due to its smaller scale and being a relatively newer entrant." 5. Varian Medical (VAR) downgraded to Sell from Neutral at Goldman Sachs with analyst Isaac Ro saying shares offer poor risk/reward versus MedTech peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TWO Two Harbors
$15.09

0.09 (0.60%)

12/07/17
KBWI
12/07/17
UPGRADE
Target $19.5
KBWI
Outperform
Granite Point upgraded to Outperform with $19.50 target at Keefe Bruyette
Keefe Bruyette analyst Jade Rahmani upgraded Granite Point Mortgage to Outperform from Market Perform with a price target of $19.50. The analyst believes the overhang from Two Harbors (TWO) and the company's "strong" management team present a buying opportunity at current share levels.
07/05/17
07/05/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pandora (P) resumed with an Overweight at Morgan Stanley. 2. Two Harbors (TWO) reinstated with an Outperform at Credit Suisse. 3. Alcentra Capital (ABDC) initiated with a Buy at DA Davidson. 4. Alon USA Partners (ALDW) reinstated with an Equal Weight at Barclays. 5. Delek US (DK) and Delek Logistics (DKL) were reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/10/17
RILY
11/10/17
UPGRADE
Target $16.5
RILY
Buy
Two Harbors upgraded to Buy on attractive valuation at B. Riley FBR
B. Riley FBR analyst Jessica Levi-Ribner upgraded Two Harbors Investment Corp. to Buy from Neutral while lowering her price target for the shares to $16.50 from $20. The analyst views the Q3 result as solid following the recent spin-out of Granite Point Mortgage Trust. The shares are as attractively valued, currently trading at a near-7% discount to book value, Levi-Ribner tells investors in a post-earnings research note.
11/10/17
RILY
11/10/17
UPGRADE
RILY
Buy
Two Harbors upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Jessica Levi-Ribner upgraded Two Harbors to Buy.
CME CME Group
$160.16

0.03 (0.02%)

02/07/18
GSCO
02/07/18
UPGRADE
Target $180
GSCO
Buy
CME Group upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Alexander Blostein upgraded CME Group to Buy and raised his price target for the shares to $180 from $160.
02/07/18
GSCO
02/07/18
UPGRADE
Target $180
GSCO
Buy
CME Group upgraded to Buy from Neutral at Goldman Sachs
Goldman analyst Alexander Blostein upgraded CME Group to Buy and raised its price target to $180 from $160. Blostein expects CME's revenue growth to accelerate in 2018/19 amid significant growth in open interest and the increasing likelihood of normalization of volatility. The analyst contends expects the prospects of rising inflation expectations and normalization of volatility to drive product velocity higher over the next two years, adding to already to the healthy build-up in open interest.
02/13/18
UBSW
02/13/18
NO CHANGE
Target $120
UBSW
Buy
Cboe Global Markets price target lowered to $120 from $136 at UBS
UBS analyst Alex Kramm lowered his price target on Cboe Global Markets (CBOE) to $120 from $136 as he sees limited room for multiple expansion and headline risk including regulatory concerns. The shares have sold off on investors concerns related to its VIX franchise and negative estimate revisions related to higher expenses and tax guidance. The analyst prefers CME (CME) as a play on higher volatility. However, Kramm maintained his buy rating on Cboe shares.
01/25/18
01/25/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. At Home Group (HOME) initiated with an Overweight at Barclays. 2. Amyris (AMRS) initiated with a Buy at B. Riley FBR. 3. Eagle Bulk Shipping (EGLE) initiated with a Buy at Deutsche Bank. 4. Flex Pharma (FLKS) initiated with a Buy at Ladenburg. 5. CME Group (CME) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CG Carlyle Group
$23.45

-0.1 (-0.42%)

12/04/17
MSCO
12/04/17
NO CHANGE
Target $28
MSCO
Overweight
Carlyle Group recent weakness a buying opportunity, says Morgan Stanley
Morgan Stanley analyst Michael Cyprys noted Carlyle Group shares have sold off by over 15% since the announcement of the company's management transition. However, he sees this pullback as a buying opportunity, as he has increased conviction in the company's ability to ramp up management fees in 2018 following a recent Bloomberg article that said its flagship North America buyout fund is approaching a cap of $18.5B, which tops the initial $15B target and would give the company $30B of global corporate private equity buying power when combined with Carlyle's Europe and Asia buyout funds. He maintains an Overweight rating and $28 price target on Carlyle shares.
02/14/18
JEFF
02/14/18
UPGRADE
Target $27
JEFF
Buy
Carlyle Group upgraded to Buy from Hold at Jefferies
Jefferies analyst Gerald E. O'Hara upgraded Carlyle Group to Buy and raised his price target for the shares to $27 from $23. The analyst sees an attractive entry point for the shares with the company at the midway point of a $100B fundraising cycle. He believes Carlyle's net accrued performance fees are poised for continued growth with all main drawdown funds currently in carry contribution.
01/30/18
MSCO
01/30/18
NO CHANGE
MSCO
Morgan Stanley says Ares may be first, Apollo may gain most from C-corp convert
Morgan Stanley analyst Michael Cyprys said he sees an opportunity for Alternative Asset Managers to unlock value by converting to C-corps, as shifting from a partnership structure could help alleviate some tax reporting complexities and expand the universe of eligible investors. He sees Ares Management (ARES) as possibly the first to convert and expects a potential announcement or indications of management's intentions about a conversion when the company reports earnings on February 15. While Ares may be first, Cyprys sees Apollo Global (APO) as potentially being able to unlock the most value from a conversion, with 26% near-term upside possible if the shares re-rate. He sees a less favorable conversion scenario for asset managers with lower taxes and/or greater exposure to performance fees, including KKR (KKR), Carlyle Group (CG) and Blackstone (BX), Cyprys tells investors.
10/10/17
10/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HSBC (HSBC) downgraded to Underperform from Neutral at Credit Suisse with analyst Sanjay Jain citing valuation. 2. Jabil Circuit (JBL) downgraded to Sell from Neutral at Goldman Sachs with analyst Mark Delaney saying street expectations, which assume Jabil's earnings grow double digits year-over-year for both of the next two years, are overly optimistic. 3. Carlyle Group (CG) downgraded to Neutral from Buy at Citi with analyst William Katz citing valuation with the shares up 60% year-to-date. 4. Eli Lilly (LLY) downgraded to Neutral from Outperform at Credit Suisse with analyst Vamil Divan saying the valuation looks full with the shares up 13% since mid-August. 5. Ralph Lauren (RL) downgraded to Sell from Hold at Miller Tabak. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/17
OPCO
11/14/17
NO CHANGE
Target $40
OPCO
Outperform
Envision buyout price could approach $50 per share, says Oppenheimer
After Bloomberg reported that private equity firms Carlyle Group (CG) and Onex have shown interest, Oppenheimer analyst Michael Wiederhorn says he believes a buyout offer for Envision Healthcare could approach $50 per share. The stock in afternoon trading is up 8% to $27.96. Such an offer is based on an 11 times 2018 EBITDA estimate, which is multiple similar to the one paid by Blackstone (BX) for Team Health in late 2016, Wiederhorn tells investors in a research note. The analyst believes Envision has a "strong growth business" and he recommends continuing to buy the shares at current levels. Wiederhorn has an Outperform rating on Envision with a $40 price target.
DFS Discover
$76.50

0.55 (0.72%)

01/26/18
ARGS
01/26/18
NO CHANGE
Target $90
ARGS
Buy
Discover price target raised to $90 from $74 at Argus
Argus analyst Stephen Biggar raised his price target on Discover to $90 and kept his Buy rating after a Q4 earnings beat. Biggar notes the 9% growth in average loans amid a strong credit card environment as well as the management's upgraded view of 7%-9% growth this year. The analyst warns that higher net charge-offs bear watching, but believes the healthy employment environment and less aggressive promotions will minimize the losses.
01/25/18
RBCM
01/25/18
NO CHANGE
Target $100
RBCM
Top Pick
Discover price target lowered to $100 from $107 at RBC Capital
RBC Capital analyst Jason Arnold lowered his price target on Discover to $100 but kept his Top Pick rating after the company's Q4 earnings. Arnold attributes the price change to higher than expected expenses from employee compensation and professional fees. The analyst notes however that performance trends continue to support a "very constructive outlook" with a lower tax rate and a favorable 2018 guidance, adding that 20% ROE and 8-10% EPS growth are "outstanding" relative to most financials.
01/25/18
JMPS
01/25/18
NO CHANGE
Target $91
JMPS
Outperform
Discover price target raised to $91 from $80 at JMP Securities
JMP Securities analyst David Scharf said Discover's operating guidance for 2018 was generally stronger than his prior forecast and he increased his 2018 and 2019 GAAP EPS estimates following the company's Q4 report. Given the updated estimates, he increased his price target on the stock to $91 and keeps an Outperform rating on Discover.
KKR KKR
$21.25

-0.28 (-1.30%)

01/10/18
FBCO
01/10/18
NO CHANGE
Target $31
FBCO
Outperform
KKR price target raised to $31 from $23 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for KKR to $31 from $23 as he believes the macro backdrop should provide tailwinds for the Alternative Asset Managers while lower corporate tax rate should boost the valuation of their underlying portfolios. The analyst reiterates an Outperform rating on the shares.
11/28/17
SDLR
11/28/17
INITIATION
Target $21
SDLR
Hold
KKR resumed with a Hold at Sandler ONeill
Sandler O'Neill resumed coverage of KKR with a Hold rating and $21 price target.
01/09/18
GSCO
01/09/18
UPGRADE
Target $29
GSCO
Conviction Buy
KKR upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Alexander Blostein upgraded KKR to Conviction Buy and raised his price target for the shares to $29 from $24.50. The analyst sees the "evolution of KKR's business mix" leading to a more stable earnings profile and higher multiple over time. KKR remains the most inexpensive stock among alternative managers, Blostein tells investors in a research note.
RF Regions Financial
$18.85

0.38 (2.06%)

01/04/18
GSCO
01/04/18
DOWNGRADE
GSCO
Buy
SunTrust downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Ryan Nash removed SunTrust (STI) from his firm's Conviction List but he keeps a Buy rating on the shares. The analyst upped his price target for the stock to $74 from $65. SunTrust does not have as much leverage to tax reform, higher short-term interest rates and deregulation as some of its peers, Nash tells investors in a research note. The analyst's top picks for 2018 are Capital One (COF), Ally Financial (ALLY), Comerica (CMA), Regions Financial (RF), KeyCorp (KEY) and Citizens Financial (CFG).
01/22/18
SDLR
01/22/18
UPGRADE
SDLR
Buy
Regions Financial upgraded to Buy from Hold at Sandler O'Neill
01/22/18
01/22/18
UPGRADE
Target $21.5

Buy
Regions Financial upgraded to Buy on higher EPS potential at Sandler ONeill
As previously reported, Sandler ONeill analyst Stephen Scouten upgraded Regions Financial to Buy from Hold after he increased his estimates for Regions in the wake of its earnings report. He sees the potential for a better expense trajectory and a quicker return to net loan growth, along with continued benefits from the bank's asset sensitive balance sheet and lower credit costs, Scouten tells investors. He raised his price target on the shares to $21.50 from $18.
02/14/18
BOFA
02/14/18
NO CHANGE
BOFA
Zions Bancorp added to US 1 List, Regions Financial removed at BofA/Merrill
02/13/18
WEDB
02/13/18
NO CHANGE
Target $21
WEDB
Outperform
Regions Financial added to Best Ideas List at Wedbush
Wedbush analyst Jesse Bigelow is adding Regions Financial to his firm's Best Ideas saying the company's hard work to reposition the balance sheet was reflected in the "solid" Q4 results and sets the stage for stronger growth in 2018. Wedbush has an Outperform rating and $21 price target on the shares.
C Citi
$75.18

0.42 (0.56%)

01/17/18
RBCM
01/17/18
NO CHANGE
Target $85
RBCM
Outperform
Citi price target raised to $85 from $79 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Citi to $85 and kept his Outperform rating following Q4 earnings. Cassidy says that non-cash charges from tax reform masked the quarter's performance, with underlying trends for Citi remaining strong. The analyst adds that CitiGroup importantly reiterated the $60B capital return goal through CCAR despite the regulatory capital hit from the tax legislation.
01/17/18
VERF
01/17/18
DOWNGRADE
VERF
Hold
Citi downgraded to Hold from Buy at Vertical Group
01/17/18
01/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Longbow with analyst Shawn Harrison saying the current iPhone cycle is "good, not great." 2. Dish (DISH) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benjamin Swinburne saying he now sees fewer likely buyers of its assets than hoped. 3. Juniper (JNPR) downgraded to Underweight from Equal Weight at Barclays with analyst Mark Moskowitz citing a lack of service provider rebound in 2018 as well as a rising threat from Arista in routing. 4. Citi (C) was downgraded to Hold from Buy at Vertical Group and to Market Perform from Outperform at Keefe Bruyette. 5. Shell Midstream (SHLX) downgraded to Hold from Buy at Stifel with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SLM Sallie Mae
$10.91

-0.04 (-0.37%)

01/08/18
OPCO
01/08/18
INITIATION
OPCO
Perform
Navient initiated with a Perform at Oppenheimer
As reported earlier, Oppenheimer analyst Ben Chittenden initiated Navient (NAVI) with a Perform rating. Chittenden says the bulk of the company revenue still comes from its legacy loan book and private student loan portfolio, and both of those segments are under pressure. The analyst adds that 2019 could mark a key turning point, when Navient's non-compete agreement with Sallie Mae (SLM) expires, allowing it to originate private student loans again.
12/12/17
FBCO
12/12/17
NO CHANGE
FBCO
Outperform
Synchrony, Discover among biggest beneficiaries of tax reform, says Credit Suisse
Credit Suisse analyst Moshe Orenbuch views tax reform as highly beneficial to U.S. consumer finance companies as most companies are full U.S. tax payers and any increases in consumer confidence from more cash flow could lead to more consumer borrowing, driving faster revenue growth and improved credit quality. His favorites to benefit from tax reform are Synchrony (SYF), Discover (DFS), OneMain (OMF), CIT Group (CIT), Santander Consumer (SC), Sallie Mae (SLM), and Air Lease (AL).
01/08/18
OPCO
01/08/18
INITIATION
Target $17
OPCO
Outperform
Sallie Mae initiated with an Outperform at Oppenheimer
As reported earlier, Oppenheimer analyst Ben Chittenden initiated Sallie Mae with an Outperform rating and a price target of $17, citing a "secular mix shift away from Federal funding of educational tuition and toward private lenders" where the company has a leading market share. The analyst says Sallie Mae will continue to benefit from better efficiency ratio, estimating mid-30s % versus "40% range" currently.
01/08/18
OPCO
01/08/18
INITIATION
Target $17
OPCO
Outperform
Sallie Mae initiated with an Outperform at Oppenheimer
Oppenheimer analyst Ben Chittenden started Sallie Mae with an Outperform rating and $17 price target.
BX Blackstone
$33.55

0.27 (0.81%)

01/31/18
MSCO
01/31/18
NO CHANGE
Target $40
MSCO
Overweight
Blackstone could be next disruptor, says Morgan Stanley
Following Blackstone's (BX) purchase of a 55% stake in Thomson Reuters' Financial and Risk business, Morgan Stanley analyst Michael Cyprys said Blackstone's deal signals the growing value in data and he sees opportunities for the asset manager to enhance its tool kit with big data and AI in order to bring transformational change to companies and industries. With nearly $100B in dry powder on which leverage can be applied, suggesting well over half trillion in spending power, Cyprys sees potential for Blackstone to act as a disruptor, he tells investors. The analyst keeps an Overweight rating and $40 price target on Blackstone shares.
01/12/18
JPMS
01/12/18
UPGRADE
Target $46
JPMS
Overweight
Blackstone upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Kenneth Worthington upgraded Blackstone to Overweight and raised his price target for the shares to $46 from $35. The analyst sees Blackstone entering its next fundraising cycle later this year and expects it to raise nearly $200B over the next two years. This should higher earnings and a higher stock price, Worthington tells investors in a research note. The analyst notes that shares have been the worst performing of the major alternative asset managers over the last two years.
01/31/18
DADA
01/31/18
NO CHANGE
Target $174
DADA
Neutral
Thomson Reuters-Blackstone F&R talks are negative for FactSet, says DA Davidson at DA Davidson
DA Davidson analyst Peter Heckmann says that yesterday's disclosure of advanced talks between Blackstone (BX) and Thomson Reuters (TRI) about the sale of the latter's Financial & Risk - F&R - operations is a negative for Factset (FDS). The analyst believes that most of the market share wins for Factset have come from Reuters over the past two decades, and Blackstone's ability to better focus investments in the financial data business may make competitive wins for difficult. Heckmann keeps his Neutral rating and $174 price target, adding "FactSet's shares will be challenged to outperform the peer group over the next year".
OAK Oaktree Capital
$42.65

-0.1 (-0.23%)

07/17/17
JMPS
07/17/17
UPGRADE
JMPS
Outperform
Fifth Street Finance upgraded on Oaktree deal at JMP Securities
As noted earlier, JMP Securities upgraded Fifth Street (FSC) to Outperform from Market Perform. Analyst Christopher York says that the deal under which Oaktree (OAK) will become Fifth Street's investment adviser will improve both companies' corporate governance and lower Fifth Street's costs. Target $8.50.
07/18/17
DBAB
07/18/17
UPGRADE
Target $6
DBAB
Buy
Fifth Street Finance upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst George Bahamondes upgraded Fifth Street Finance (FSC) to Buy and raised his price target for the shares to $6 from $4.75. The analyst believes the deal with Oaktree Capital (OAK) as a "step in the right direction." He thinks Oaktree's credit and operational experience will be an asset to Fifth Street.
07/28/17
GSCO
07/28/17
DOWNGRADE
Target $49
GSCO
Neutral
Oaktree Capital downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Alexander Blostein downgraded Oaktree Capital to Neutral and lowered his price target for the shares to $49 from $50. The analyst sees the company's 2018 and 2019 cash earnings growth slowing amid a softer near-term fee-related earnings outlook and tougher comps for incentive fees.
11/09/17
MSCO
11/09/17
NO CHANGE
MSCO
Morgan Stanley says GOP proposals would only have 'modest impact' on PE markets
Morgan Stanley analyst Michael Cyprys noted that the House GOP tax proposal would limit interest deductibility, which has led to concerns over the future of private equity use of leverage and the potential for reduced supply in the high yield bond market. However, he thinks incrementally higher LBO funding costs and interest deductibility limitations should not be a major headwind for supply. Regardless of the final shape of a tax bill, change could create market dislocations and "there will be winners and losers," Cyprys tells investors. He views Oaktree Capital (OAK) as best positioned for dislocation given its dry powder and skew toward distressed investing, but also sees Blackstone (BX) and Apollo Global (APO) as well positioned.
MS Morgan Stanley
$53.39

-0.04 (-0.07%)

01/09/18
SOCG
01/09/18
DOWNGRADE
Target $59.5
SOCG
Hold
Morgan Stanley downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Andrew Lim downgraded Morgan Stanley to Hold saying the stock is now fairly priced following the recent rally. The analyst raised his price target for the shares to $59.50 from $55.
01/10/18
01/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Neutral from Underweight at Atlantic Equities by analyst John Heagerty, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Wells Fargo shares to $64 from $55. The analyst also upgraded Morgan Stanley (MS) to Overweight this morning, citing the same analysis of the potential benefits from tax reform. 2. Deere upgraded to Outperform from Sector Perform at RBC Capital by analyst Seth Weber, who said he is positive on the company's leadership position in North American farm machinery which is stabilizing and exposure to the earth moving equipment category. The analyst is also constructive on Deere's recent Wirten Group acquisition. 3. Target (TGT) upgraded to Positive from Neutral at Susquehanna. 4. State Street (STT) and BNY Mellon (BK) upgraded to Buy from Neutral at Citi, with analyst Keith Horowitz saying he thinks the trust banks are the best way to play the digital transformation to the cloud and finds the current valuation as attractive. 5. RBS (RBS) upgraded to Overweight from Equal Weight at Morgan Stanley. Analyst Alvaro Serrano also downgraded Barclays (BCS) and Lloyds Banking (LYG). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/18
ATLE
01/10/18
UPGRADE
Target $61
ATLE
Overweight
Morgan Stanley upgraded on tax reform benefits at Atlantic Equities
As previously reported, Atlantic Equities analyst John Heagerty upgraded Morgan Stanley (MS) to Overweight from Neutral, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Morgan Stanley shares to $61 from $48. The analyst also upgraded Wells Fargo (WFC) to Neutral from Underweight this morning, citing the same analysis of the potential benefits from tax reform.
01/10/18
ATLE
01/10/18
UPGRADE
ATLE
Overweight
Morgan Stanley upgraded to Overweight from Neutral at Atlantic Equities
SPGI S&P Global
$181.94

1.58 (0.88%)

02/07/18
FBCO
02/07/18
NO CHANGE
Target $222
FBCO
Outperform
S&P Global price target raised to $222 from $183 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for S&P Global to $222 from $183 after the company reported another "strong" quarter, with the Ratings business again driving upside to his expectations, on "very strong" transaction revenue. The analyst reiterates an Outperform rating on the shares.
02/07/18
SUSQ
02/07/18
DOWNGRADE
SUSQ
Neutral
S&P Global downgraded to Neutral from Positive at Susquehanna
01/11/18
NOMU
01/11/18
INITIATION
Target $180
NOMU
Buy
Moody's initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Dan Dolev started Moody's (MCO) with a Buy rating and $180 price target. The analyst prefers the stock over S&P Global (SPGI) citing its "superior execution" in ratings and opportunities to improve growth and margin in analytics.
01/11/18
NOMU
01/11/18
INITIATION
Target $160
NOMU
Neutral
S&P Global initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Dan Dolev started S&P Global with a Neutral rating and $160 price target. The analyst believes "recent sharp cuts" in supervisors could weigh on the company's product quality and future margin growth.
MTGE MTGE Investment
$17.25

0.25 (1.47%)

05/04/17
WELS
05/04/17
UPGRADE
WELS
Outperform
MTGE Investment upgraded to Outperform from Market Perform at Wells Fargo
05/05/17
WELS
05/05/17
UPGRADE
WELS
Outperform
MTGE Investment Corp. upgraded on ROE improvement, valuation at Wells Fargo
As noted earlier, Wells Fargo upgraded MTGE to Outperform from Market Perform. As reasons for the upgrade, the firm cited the strong return on equity of the company's healthcare and agency units, valuation, and AGNC Investment's (AGNC) recent authorization to purchase its shares. Target to $18.50-$20.50 from $16-$17.
NTRS Northern Trust
$99.35

-0.01 (-0.01%)

08/09/17
WELS
08/09/17
INITIATION
Target $90
WELS
Market Perform
Northern Trust initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo started Northern Trust with a Market Perform rating and $90 price target.
01/25/18
RBCM
01/25/18
NO CHANGE
Target $110
RBCM
Outperform
Northern Trust price target raised to $110 from $97 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Northern Trust to $110 and kept his Outperform rating after Q4 results that were supported by strength in C&IS business, wealth management, and net interest income. The analyst adds that the company's capital levels are "robust" as it remains committed to returning excess capital to shareholders.
12/20/17
WELS
12/20/17
NO CHANGE
Target $105
WELS
Market Perform
Northern Trust price target raised to $105 from $95 at Wells Fargo
Wells Fargo analyst Mike Mayo raised his price target for Northern Trust to $105 from $95 to reflect more potential upside from a portion of higher interest rates, lower taxes, and lower cost of capital due to greater resiliency. The analyst reiterates a Market Perform rating on the shares.
09/08/17
UBSW
09/08/17
UPGRADE
UBSW
Buy
Northern Trust upgraded to Buy from Neutral at UBS

TODAY'S FREE FLY STORIES

TSLA

Tesla

$347.49

-14.69 (-4.06%)

21:14
06/21/18
06/21
21:14
06/21/18
21:14
Periodicals
Tesla job cuts to concentrate on the solar facilities, Reuters says »

As part of the 9% staff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

ECOR

ElectroCore

$0.00

(0.00%)

21:08
06/21/18
06/21
21:08
06/21/18
21:08
Syndicate
ElectroCore 5.2M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

TELNY

Telenor

$0.00

(0.00%)

20:43
06/21/18
06/21
20:43
06/21/18
20:43
Upgrade
Telenor rating change  »

Telenor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$71.05

-1.77 (-2.43%)

20:25
06/21/18
06/21
20:25
06/21/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.28

-1.72 (-0.62%)

, SPX

S&P 500

$0.00

(0.00%)

20:07
06/21/18
06/21
20:07
06/21/18
20:07
Periodicals
Money market funds pull the most funds since 2011, Reuters says »

Investors pulled $51B in…

SPY

SPDR S&P 500 ETF Trust

$274.28

-1.72 (-0.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANZBY

ANZ Banking

$0.00

(0.00%)

19:53
06/21/18
06/21
19:53
06/21/18
19:53
Hot Stocks
ANZ Bank doubles share buyback to AUD 3B »

ANZ announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$185.48

-1.06 (-0.57%)

, QCOM

Qualcomm

$58.76

-0.03 (-0.05%)

19:50
06/21/18
06/21
19:50
06/21/18
19:50
Periodicals
Apple challenges four patents held by Qualcomm at USPTO, Bloomberg says »

Apple (AAPL) filed…

AAPL

Apple

$185.48

-1.06 (-0.57%)

QCOM

Qualcomm

$58.76

-0.03 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CS

Credit Suisse

$15.01

-0.2 (-1.31%)

19:42
06/21/18
06/21
19:42
06/21/18
19:42
Periodicals
Federal judge rules in Credit Suisse favor in a $300M broker suit, Reuters says »

A San Francisco federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$26.45

-0.8 (-2.94%)

, FUJIY

Fujifilm

$0.00

(0.00%)

19:19
06/21/18
06/21
19:19
06/21/18
19:19
Periodicals
Xerox judge rejects Fuji request to end deal vote injunction, Bloomberg says »

Fujifilm Holdings (FUJIY)…

XRX

Xerox

$26.45

-0.8 (-2.94%)

FUJIY

Fujifilm

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

19:11
06/21/18
06/21
19:11
06/21/18
19:11
Hot Stocks
Airbus says no-deal Brexit would lead to 'severe disruption' of U.K. production »

Airbus said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

, MDT

Medtronic

$86.29

0.11 (0.13%)

19:00
06/21/18
06/21
19:00
06/21/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Tandem Diabetes…

TNDM

TNDM

MDT

Medtronic

$86.29

0.11 (0.13%)

RHT

Red Hat

$165.62

-3.64 (-2.15%)

VMW

VMware

$152.08

-0.07 (-0.05%)

SPLK

Splunk

$113.06

-2.8 (-2.42%)

SGH

Smart Global

$39.79

-0.72 (-1.78%)

TCS

Container Store

$8.73

0.08 (0.92%)

LRCX

Lam Research

$176.01

1.54 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 07

    Jul

  • 09

    Jul

  • 10

    Jul

  • 10

    Jul

  • 10

    Jul

  • 12

    Jul

  • 12

    Jul

  • 12

    Jul

BDRBF

Bombardier

$0.00

(0.00%)

, ERJ

Embraer

$25.48

-0.2 (-0.78%)

18:53
06/21/18
06/21
18:53
06/21/18
18:53
Periodicals
Bombardier sees CRJ 900 winning 'half or more' of market share, Reuters says »

Bombardier's (BDRBF)…

BDRBF

Bombardier

$0.00

(0.00%)

ERJ

Embraer

$25.48

-0.2 (-0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 02

    Aug

WOW

WideOpenWest

$9.44

-0.2497 (-2.58%)

18:37
06/21/18
06/21
18:37
06/21/18
18:37
Initiation
WideOpenWest initiated at B. Riley FBR »

WideOpenWest initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CABO

Cable One

$716.20

-2.81 (-0.39%)

18:37
06/21/18
06/21
18:37
06/21/18
18:37
Initiation
Cable One initiated at B. Riley FBR »

Cable One initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

, DIS

Disney

$105.89

-1.39 (-1.30%)

18:32
06/21/18
06/21
18:32
06/21/18
18:32
Hot Stocks
Disney offers to divest Fox assets generating up to $1B in EBITDA »

In a regulatory filing,…

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

DIS

Disney

$105.89

-1.39 (-1.30%)

CMCSA

Comcast

$32.80

-0.595 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$86.29

0.11 (0.13%)

18:29
06/21/18
06/21
18:29
06/21/18
18:29
Hot Stocks
Medtronic announces FDA approval of MiniMed 670G system »

Medtronic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

AEO

American Eagle

$25.27

0.615 (2.49%)

18:23
06/21/18
06/21
18:23
06/21/18
18:23
Hot Stocks
American Eagle director Page sells 44,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,157.63

-11.75 (-1.00%)

, GOOGL

Alphabet Class A

$1,169.56

-14.27 (-1.21%)

18:19
06/21/18
06/21
18:19
06/21/18
18:19
Periodicals
YouTube to let content creators sell monthly subscriptions, Bloomberg says »

Google's YouTube is…

GOOG

Alphabet

$1,157.63

-11.75 (-1.00%)

GOOGL

Alphabet Class A

$1,169.56

-14.27 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

NMR

Nomura

$4.85

-0.075 (-1.52%)

18:09
06/21/18
06/21
18:09
06/21/18
18:09
Periodicals
Nomura to cut 40 global markets traders in the U.S., Bloomberg says »

Nomura is expected to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$120.06

-0.2 (-0.17%)

18:02
06/21/18
06/21
18:02
06/21/18
18:02
Hot Stocks
SPDR Gold Trust holdings fall to 824.63MT from 828.76MT »

This is the first decline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.37

-0.13 (-0.24%)

17:50
06/21/18
06/21
17:50
06/21/18
17:50
Periodicals
Wells Fargo said to let go of 10 analysts to cut costs, Bloomberg reports »

Wells Fargo has laid off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Apr

  • 16

    Jul

  • 15

    Oct

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

, DIS

Disney

$105.89

-1.39 (-1.30%)

17:47
06/21/18
06/21
17:47
06/21/18
17:47
Periodicals
Breaking Periodicals news story on 21st Century Fox, Disney, Comcast »

Disney to double asset…

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

DIS

Disney

$105.89

-1.39 (-1.30%)

CMCSA

Comcast

$32.80

-0.595 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTA

Enanta

$118.81

3.54 (3.07%)

17:45
06/21/18
06/21
17:45
06/21/18
17:45
Conference/Events
Enanta management to meet with Oppenheimer »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

TNTR

Tintri

$0.20

0.0369 (22.38%)

17:32
06/21/18
06/21
17:32
06/21/18
17:32
Hot Stocks
Tintri receives Nasdaq noncompliance notice from 10-Q filing delay »

Tintri received a notice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUE

Cue Biopharma

$12.41

0.18 (1.47%)

17:25
06/21/18
06/21
17:25
06/21/18
17:25
Syndicate
Breaking Syndicate news story on Cue Biopharma »

Cue Biopharma files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.